Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:09 AM
Ignite Modification Date:
2025-12-25 @ 5:09 AM
NCT ID:
NCT04404127
Eligibility Criteria:
Inclusion Criteria:
* • Male or female ≥ 18 years
* Living donor
* Low immunological risk (defined as):
1. First (primary) transplant
2. ≤ 4 antigen mismatches (HLA matching scheme)
3. Negative HLA Ab screening
Exclusion Criteria:
* • High immunological risk
* HLA identical or zero mismatched transplants
* Receiving cyclosporin as primary maintenance immunosuppressant
* Human immunodeficiency virus (HIV) co-infection
* Pregnant or nursing female
* Has received an investigational medication within the past 30 days
* Has a known contraindication to the administration of Basiliximab
* Suspected or known to have a serious infection
* Multi-organ transplant
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT04404127
Study Brief:
Protocol Section:
NCT04404127